Dr. Pepose is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1815 Clarkson Rd
Chesterfield, MO 63017Phone+1 636-728-0111Fax+1 636-728-1262
Summary
- Dr. Jay Pepose is an ophthalmologist in Chesterfield, MO and is affiliated with multiple hospitals in the area, including Barnes-Jewish St Peters Hospital, Missouri Baptist Medical Center, and Mercy Hospital St. Louis. He received his medical degree from David Geffen School of Medicine at UCLA and has been in practice 35 years. He specializes in cataract related, cornea & external disease, and refractive surgery and is experienced in cataracts, refractive surgery, laser in situ keratomileusis, cataract surgery, and cornea / external disease.
Education & Training
- Johns Hopkins UniversityResidency, Ophthalmology, 1984 - 1987
- UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Internal Medicine, 1982 - 1984
- David Geffen School of Medicine at UCLAClass of 1982
Certifications & Licensure
- CA State Medical License 1983 - 2027
- MO State Medical License 1988 - 2026
- IL State Medical License 1998 - 2017
- American Board of Ophthalmology Ophthalmology
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2002-2014
- CMS Meaningful Use Stage 1 Certification RcopiaMU EHR, DrFirst.com, Inc., 2013
- St. Louis Magazine: Top Doctors Castle Connolly, 2001
- Join now to see all
Clinical Trials
- Toric Intraocular Lens Following Cataract Surgery Start of enrollment: 2010 Jun 01
- Efficacy of FreshKote and Systane for the Treatment of Dry Eye and Improvement of Osmolarity Start of enrollment: 2011 Jul 01
- Safety & Efficacy of Corneal Collagen Cross-Linking in Eyes With Keratoconus or Corneal Ectasia After Refractive Surgery Start of enrollment: 2012 Jul 01
- Join now to see all
Publications & Presentations
PubMed
- Reversal of Pharmacologically Induced Mydriasis with Phentolamine Ophthalmic Solution.Jay S Pepose, David Wirta, David Evans, Barbara Withers, Kavon Rahmani
Ophthalmology. 2024-09-16 - 3 citationsA randomized phase 2 clinical trial of phentolamine mesylate eye drops in patients with severe night vision disturbances.Jay Pepose, Mitchell Brigell, Eliot Lazar, Curtis Heisel, Jonah Yousif
BMC Ophthalmology. 2022-10-08 - 14 citationsExpert consensus on the identification, diagnosis, and treatment of neurotrophic keratopathy.Reza Dana, Marjan Farid, Preeya K. Gupta, Pedram Hamrah, Paul M. Karpecki
BMC Ophthalmology. 2021-09-08
Press Mentions
- Nyxol Ophthalmic Solution Looks Promising for Night Vision DisturbancesMay 20th, 2022
- Ocuphire Announces Positive Topline Results from LYNX-1 Phase 3 Trial Evaluating Nyxol® Eye Drops for Night Vision DisturbancesMay 19th, 2022
- Ocuphire Appoints Jay Pepose, M.D., Ph.D., as Chief Medical Advisor and Announces Upcoming Presentations at ASCRS 2022 and EyeceleratorApril 19th, 2022
- Join now to see all
Professional Memberships
- Fellow
External Links
- Pepose Vision Institutehttp://www.peposevision.com
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: